- Reported purity
- 99.87%99.5%+
- Test date
- May 16, 2026
- Laboratory named
- Freedom Diagnostics
Lot details
TS-0429-NAD-A
Market
T
Popular
27% below market
on 7 popular peptides
Catalog
27% below market
$ price level · 8 listings
Peptides
7
7 popular carried
COA coverage, in stock
6 of 6
100% of in-stock products · in-stock vendor median 54%
Cheapest on
- Tirzepatide▼ 61%
- Retatrutide▼ 50%
- NAD+▼ 36%
Pricier on
- Tesamorelin▲ 5%
Price check
Listed prices at True Sciences against the median price per mg for the same peptide at the same vial size, across every vendor we track. Vendors change prices without notice, so check the current listing before you order.
Tirzepatide15 mg vial · lowest elsewhere $3.93/mg at Pure Health Peptides▼ 61%$3/mgRetatrutide10 mg vial · lowest elsewhere $4.20/mg at NextGen Peptides▼ 50%$4.50/mgNAD+500 mg vial · lowest elsewhere $0.07/mg at Ion Peptide▼ 36%$0.09/mgBPC-15710 mg vial · lowest elsewhere $2/mg at Grey Axis Research▼ 18%$4.50/mgMOTS-c10 mg vial · lowest elsewhere $2.29/mg at Grey Axis Research▼ 17%$4.50/mgTesamorelin10 mg vial · lowest elsewhere $3.90/mg at retaone▲ 5%$7.90/mg
Below the market median on 5 of 6 comparable listings, above it on 1. Typical listing: 27% below market.
Popular peptides
7 of 22 carriedFull catalog (7)
Product documentation
True Sciences COA coverage
Current certificates are on file for 6 of 7 tracked peptide products from True Sciences. The public index contains 7 documents. Reported test dates in this set run from May 6, 2026 through May 16, 2026. That coverage figure counts the full tracked catalogue for True Sciences, including products that are currently out of stock, so it can differ from the in-stock figure above.
- Product coverage
- 6 of 7
- Tested in past year
- 6 of 6
- Older records
- 0
- Most named lab
- Freedom Diagnostics
86% · tracked-vendor median 54%
Based on the printed test date.
Printed date is over 18 months old.
100% of current records that name a lab.
6 current records
View COA
- Reported purity
- 99.34%99.0–99.49%
- Test date
- May 16, 2026
- Laboratory named
- Freedom Diagnostics
Lot details
TS-0429-TESA-A
- Reported purity
- 99.4%99.0–99.49%
- Test date
- May 6, 2026
- Laboratory named
- Freedom Diagnostics
Lot details
TS-0429-BPC-A
- Reported purity
- 99.46%99.0–99.49%
- Test date
- May 6, 2026
- Laboratory named
- FREEDOM DIAGNOSTICS
Lot details
TS-0429-MOTSC
- Reported purity
- 99.9%99.5%+
- Test date
- May 6, 2026
- Laboratory named
- Freedom Diagnostics
Lot details
TS-0429-GLP3-A
- Reported purity
- 99.95%99.5%+
- Test date
- May 6, 2026
- Laboratory named
- Freedom Diagnostics
Lot details
TS-0429-GLP2-A
| Printed lab | Certificate | |||
|---|---|---|---|---|
| NAD+ | Freedom Diagnostics | May 16, 2026 | 99.87%99.5%+ | View COA |
| Tesamorelin | Freedom Diagnostics | May 16, 2026 | 99.34%99.0–99.49% | View COA |
| BPC-157 | Freedom Diagnostics | May 6, 2026 | 99.4%99.0–99.49% | View COA |
| MOTS-c | FREEDOM DIAGNOSTICS | May 6, 2026 | 99.46%99.0–99.49% | View COA |
| Retatrutide | Freedom Diagnostics | May 6, 2026 | 99.9%99.5%+ | View COA |
| Tirzepatide | Freedom Diagnostics | May 6, 2026 | 99.95%99.5%+ | View COA |
A record appears on file after our pipeline identifies the document as a certificate of analysis and matches its printed compound to a catalog peptide. The record cannot prove authenticity, chain of custody, sterility, product safety, or suitability for use.
These numbers measure document coverage only. They do not grade vendor quality, legitimacy, or safety. Printed fields can contain transcription errors. “Older record” means the reported test date is more than 18 months old.
See the testing methodology and dataset, or compare this coverage against another vendor in the vendor comparison tool.